Noradrenaline, infused locally, reduces arrhythmia severity during coronary artery occlusion in anaesthetised dogs

Cardiovascular Research

Volumn 55, Issue 1, 2002, Pages 53-63

  Végh, Ágnes ^a   Parratt, James R ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Arrhythmia (mechanisms); Ischemia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ANESTHETIC AGENT; CHLORALOSE; GUANETHIDINE; ISOPRENALINE; NORADRENALIN; PHENYLEPHRINE; PROTEIN KINASE C; SODIUM CHLORIDE; URETHAN;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DISEASE SEVERITY; DOG; DRUG MECHANISM; EPICARDIUM; FEMALE; HEART BEAT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; INCIDENCE; MALE; NONHUMAN; PATHOGENESIS; PRESYNAPTIC NERVE; PRIORITY JOURNAL; ST SEGMENT; SURVIVAL; TACHYCARDIA; TIME;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ANALYSIS OF VARIANCE; ANESTHESIA; ANIMALS; ARRHYTHMIA; CASE-CONTROL STUDIES; CHLORALOSE; CORONARY VESSELS; DOGS; FEMALE; HEMODYNAMIC PROCESSES; INFUSIONS, INTRA-ARTERIAL; ISOPROTERENOL; MALE; MODELS, ANIMAL; MYOCARDIAL REPERFUSION INJURY; NOREPINEPHRINE; PHENYLEPHRINE; URETHANE;

EID: 0036270008     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00342-5     Document Type: Article

References (43)

1. Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure
2. Cardiac transplantation does not effect ischaemia-induced arrhythmias in rats
3. Role of sympathoadrenergic mechanisms in arrhythmogenesis
4. Are the arrhythmias due to myocardial ischaemia and infarction dependent upon the sympathetic system?
5. The possible role of the sympathetic nervous system in the genesis of early post-ischaemia arrhythmias
6. Cardiac sympathetic activity in myocardial ischemia: Release and effects of noradrenaline
7. Myocardial metabolism and function during ischaemia: Response to l-noradrenaline
8. Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat
9. Catecholamines and early post-infarction arrhythmias: The effects of α- and β-adrenoceptor blockade
10. Pretreatment with catecholamines can suppress severe ventricular arrhythmias in rats: Relevance to ischemic preconditioning
11. 1-adrenergic mechanism
12. Transient β-adrenergic stimulation can precondition the rat heart against postischaemic contractile dysfunction
13. 1-adrenergic receptor agonist-induced preconditioning in isolated working rat hearts
14. α-Adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning
15. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C
16. Protection of myocardium by transient, preischemic administration of phenylephrine in the rabbit
17. 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5′-nucleotidase activity
18. 1-receptor aginist, methoxamine, does not reproduce the infarct-limiting effect of ischemic preconditioning in dogs
19. Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium
20. Effect of catecholamine depletion on infarct size in dogs: Role of catecholamines in ischemic preconditioning
21. Preconditioning of isolated rat heart is mediated by protein kinase C
22. Intracoronary noradrenaline suppresses ischaemia-induced arrhythmias in anaesthetised dogs
23. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats
24. The Lambeth Conventions: Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion
25. The dopamine receptor agonist Z1046 reduces ischaemia severity in a canine model of coronary artery occlusion
26. Adrenergic neurone blocking agents
27. Time course of the protection against ischaemia and reperfusion-induced ventricular arrhythmias resulting from brief periods of cardiac pacing
28. Pacing-induced delayed protection against arrhythmias is attenuated by aminoguanidine, an inhibitor of nitric oxide synthase
29. Catecholamines can induce adenosine receptor mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit
30. 1-adrenoceptors and protein synthesis
31. 1-adrenoceptors
32. Effects of alterations in sympathetic nervous activity on the severity of reperfusion-induced arrhythmias in anaesthetised rats
33. 1-adrenergic receptor antagonists on susceptibility to malignant arrhythmias: Protection from ventricular fibrillation
34. The early consequences of myocardial ischaemia and their modification
35. 1-adrenoceptors in ischaemic and reperfusion injury of the myocardium
36. An antiarrhythmic effect of adenosine during myocardial ischaemia and reperfusion
37. 2-adrenergic receptors in the regulation of myocardial performance during exercise in conscious dogs
38. 1-Adrenoceptors: Function and phosphorylation
39. Ischemic preconditioning: From basic mechanisms to clinical applications
40. 1-Adrenergic stimulation enhances inducible nitric oxide synthase expression in rat cardiac myocytes
41. Exercise 24 h prior to coronary artery occlusion reduces arrhythmia severity in dogs: Role of nitric oxide
42. Delayed cardioprotective effects of exercise in dogs are aminogluanidine sensitive: Possible involvement of nitric oxide
43. Cardiac pacing-induced delayed protection against ventricular arrhythmias. Evidence for the role of nitric oxide